Furosemide is associated with acute kidney injury in critically ill patients

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 9, 2012, Pages 827-833

  Levi, T M ^a,b   Rocha, M S ^c   Almeida, D N ^d   Martins, R T C ^e   Silva, M G C ^c   Santana, N C P ^c   Sanjuan, I T ^c   Cruz, C M S ^c,f  

^a DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^b Unio Metropolitana de Ensino e Cultura   (Brazil)

^c ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^d Hospital Calixto Midlej Filho   (Brazil)

^e FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^f Obras Sociais Irmã Dulce   (Brazil)

Author keywords

Acute renal failure; Critically ill patients; Furosemide; Septic shock

Indexed keywords

DIURETIC AGENT; FUROSEMIDE;

ACUTE KIDNEY FAILURE; ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; CRITICALLY ILL PATIENT; DIURETIC THERAPY; DRUG USE; ETHNICITY; FEMALE; HEART RATE; HEMATOCRIT; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PREDICTION; SEPTIC SHOCK; UNIVARIATE ANALYSIS;

EID: 84865398753     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500093     Document Type: Article

References (38)

1. Hilton R. Acute renal failure. BMJ 2006; 333: 786-790.
2. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
3. Bucuvic EM, Ponce D, Balbi AL. Risk factors for mortality in acute kidney injury. Rev Assoc Med Bras 2011; 57: 158-163.
4. Samimagham HR, Kheirkhah S, Haghighi A, Najmi Z. Acute kidney injury in intensive care unit: incidence, risk factors and mortality rate. Saudi J Kidney Dis Transpl 2011; 22: 464-470.
5. Dennen P, Douglas IS, Anderson R. Acute kidney injury in the intensive care unit: an update and primer for the intensivist. Crit Care Med 2010; 38: 261-275.
6. Mehta RL, Pascual MT, Soroko S, Chertow GM. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002; 288: 2547-2553.
7. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006; 333: 420.
8. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, doubleblind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997; 12: 2592-2596.
9. Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Diuretics and mortality in acute renal failure. Crit Care Med 2004; 32: 1669-1677.
10. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818.
11. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34: 1913-1917.
12. Mehta RL, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int 2004; 66: 1613-1621.
13. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007; 35: 1837-1843.
14. Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496-507.
15. Suarez-Kurtz G. Pharmacogenomics and the genetic diversity of the Brazilian population. Cad Saúde Pública 2009; 25: 1650-1651.
16. Mattu A, Martinez JP, Kelly BS. Modern management of cardiogenic pulmonary edema. Emerg Med Clin North Am 2005; 23: 1105-1125.
17. Karkouti K, Beattie WS, Wijeysundera DN, Rao V, Chan C, Dattilo KM, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 2005; 129: 391-400.
18. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004; 15: 1597-1605.
19. Vivino G, Antonelli M, Moro ML, Cottini F, Conti G, Bufi M, et al. Risk factors for acute renal failure in trauma patients. Intensive Care Med 1998; 24: 808-814.
20. Bellomo R, Wan L, May C. Managing septic acute renal failure: "fill and spill"? "squeeze and diurese"? or "block Bax to the max"? Crit Care Resusc 2004; 6: 12-16.
21. Molitoris BA, Sandoval RM. Intravital multiphoton microscopy of dynamic renal processes. Am J Physiol Renal Physiol 2005; 288: F1084-F1089.
22. Wu L, Gokden N, Mayeux PR. Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol 2007; 18: 1807-1815.
23. Dagher PC, Herget-Rosenthal S, Ruehm SG, Jo SK, Star RA, Agarwal R, et al. Newly developed techniques to study and diagnose acute renal failure. J Am Soc Nephrol 2003; 14: 2188-2198.
24. Langenberg C, Bellomo R, May CN, Egi M, Wan L, Morgera S. Renal vascular resistance in sepsis. Nephron Physiol 2006; 104: 1-11.
25. Molitoris BA. Renal blood flow in sepsis: a complex issue. Crit Care 2005; 9: 327-328.
26. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858-873.
27. Russell JA. Management of sepsis. N Engl J Med 2006; 355: 1699-1713.
28. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
29. Brezis M, Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 1995; 332: 647-655.
30. Sheridan AM, Bonventre JV. Pathophysiology of ischemic acute renal failure. Contrib Nephrol 2001; 7-21.
31. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
32. Evans RG, Madden AC, Denton KM. Diversity of responses of renal cortical and medullary blood flow to vasoconstrictors in conscious rabbits. Acta Physiol Scand 2000; 169: 297-308.
33. Guild SJ, Eppel GA, Malpas SC, Rajapakse NW, Stewart A, Evans RG. Regional responsiveness of renal perfusion to activation of the renal nerves. Am J Physiol Regul Integr Comp Physiol 2002; 283: R1177-R1186.
34. Silke B. Haemodynamic impact of diuretic therapy in chronic heart failure. Cardiology 1994; 84 (Suppl 2): 115-123.
35. Pickkers P, Dormans TP, Russel FG, Hughes AD, Thien T, Schaper N, et al. Direct vascular effects of furosemide in humans. Circulation 1997; 96: 1847-1852.
36. Dobrowolski L, Baddzynska B, Sadowski J. Differential effect of frusemide on renal medullary and cortical blood flow in the anaesthetised rat. Exp Physiol 2000; 85: 783-789.
37. Dobrowolski L, Badzynska B, Grzelec-Mojzesowicz M, Sadowski J. Renal vascular effects of frusemide in the rat: influence of salt loading and the role of angiotensin II. Exp Physiol 2001; 86: 611-616.
38. Castrop H, Vitzthum H, Schumacher K, Schweda F, Kurtz A. Low tonicity mediates a downregulation of cyclooxygenase-1 expression by furosemide in the rat renal papilla. J Am Soc Nephrol 2002; 13: 1136-1144.